Zynteglo
NDC 73554-3111, betibeglogene autotemcel, suspension, from Genetix Biotherapeutics Inc..
- Product NDC
- 73554-3111
- Status
- Listed
- Labeler
- Genetix Biotherapeutics Inc.
- Dosage form
- SUSPENSION
- Route
- INTRAVENOUS
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125717
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73554-3111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BETIBEGLOGENE AUTOTEMCEL20000000 1/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73554-3111-1 | 73554311101 | 1 SUSPENSION in 1 BAG (73554-3111-1) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 73554-3111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73554-3111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73554-3111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.